Top of this page
Skip navigation, go straight to the content


UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions.

Celebrating 90 years of innovation #UCB90



UCB Ventures, a strategic corporate venture fund established in 2017 to further strengthen UCB’s ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases, has announced its first direct investment.

image description